Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects

doi:10.1186/s40942-019-0157-z

Editorial

. 2019 Mar 6:5:8.

doi: 10.1186/s40942-019-0157-z. eCollection 2019.

Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects

Sandeep Saxena¹, Timothy Y Lai², Hideki Koizumi³, Michel E Farah⁴, Daniela Ferrara⁵, David Pelayes⁶, Tomohito Sato⁷, Carsten H Meyer⁸, Timothy Murray⁹; International Pharmacokinetic Collaboration

Collaborators, Affiliations

Collaborators

Affiliations

¹ 1Department of Ophthalmology, King George's Medical University, Lucknow, India.
² Hong Kong Eye Hospital, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
³ 3Department of Ophthalmology, University of the Ryukyus, Okinawa, Japan.
⁴ 4Department of Ophthalmology, Federal University of Sao Paulo (UNIFESP), São Paulo, Brazil.
⁵ 5Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts USA.
⁶ 6Department of Ophthalmology, Buenos Aires University and Maimonides University, Buenos Aires, Argentina.
⁷ 7Department of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
⁸ Department of Ophthalmology, Smartlook, Aarau, Switzerland.
⁹ 9Bascom Palmer Eye Institute, University of Miami, Miami, FL USA.

PMID: 30873293
PMCID: PMC6402161
DOI: 10.1186/s40942-019-0157-z

Editorial

Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects

Sandeep Saxena et al. Int J Retina Vitreous. 2019.

. 2019 Mar 6:5:8.

doi: 10.1186/s40942-019-0157-z. eCollection 2019.

Authors

Collaborators

Affiliations

¹ 1Department of Ophthalmology, King George's Medical University, Lucknow, India.
² Hong Kong Eye Hospital, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
³ 3Department of Ophthalmology, University of the Ryukyus, Okinawa, Japan.
⁴ 4Department of Ophthalmology, Federal University of Sao Paulo (UNIFESP), São Paulo, Brazil.
⁵ 5Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts USA.
⁶ 6Department of Ophthalmology, Buenos Aires University and Maimonides University, Buenos Aires, Argentina.
⁷ 7Department of Ophthalmology, National Defense Medical College, Tokorozawa, Japan.
⁸ Department of Ophthalmology, Smartlook, Aarau, Switzerland.
⁹ 9Bascom Palmer Eye Institute, University of Miami, Miami, FL USA.

PMID: 30873293
PMCID: PMC6402161
DOI: 10.1186/s40942-019-0157-z

Abstract

A paracentesis prior to an intravitreal injection is a very safe procedure and can prevent IOP-spikes after injections. As these spikes pose the risk of inducing glaucomatous changes particularly in patients with frequent injections and/or with a risk profile, a regular paracentesis prior to an injection may be considered and discussed with the patient.

PubMed Disclaimer

Cited by

Effect of Intravitreal Injections on Retinal Imaging Metrics in Glaucomatous and Non-Glaucomatous Eyes.
Nuesi R, Swaminathan SS. Nuesi R, et al. Curr Ophthalmol Rep. 2020 Sep;8(3):111-119. doi: 10.1007/s40135-020-00235-z. Epub 2020 Jun 4. Curr Ophthalmol Rep. 2020. PMID: 33738146 Free PMC article.
Background diseases and the number of previous intravitreal aflibercept injections on immediate intraocular pressure increase and vitreous reflux rate in phakic eyes.
Muto T, Machida S, Imaizumi S. Muto T, et al. Int J Ophthalmol. 2024 Mar 18;17(3):545-550. doi: 10.18240/ijo.2024.03.17. eCollection 2024. Int J Ophthalmol. 2024. PMID: 38721500 Free PMC article.
Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD.
Swaminathan SS, Kunkler AL, Quan AV, Medert CM, Vanner EA, Feuer W, Chang TC. Swaminathan SS, et al. Am J Ophthalmol. 2021 Jun;226:206-216. doi: 10.1016/j.ajo.2020.12.016. Epub 2020 Dec 24. Am J Ophthalmol. 2021. PMID: 33359714 Free PMC article.
Exosomal miR-184 in the aqueous humor of patients with central serous chorioretinopathy: a potential diagnostic and prognostic biomarker.
Yang JM, Kim SJ, Park S, Son W, Kim A, Lee J. Yang JM, et al. J Nanobiotechnology. 2023 Jul 28;21(1):242. doi: 10.1186/s12951-023-02019-6. J Nanobiotechnology. 2023. PMID: 37507708 Free PMC article.
Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept.
Sato T, Enoki T, Karasawa Y, Someya H, Taguchi M, Harimoto K, Takayama K, Kanda T, Ito M, Takeuchi M. Sato T, et al. Front Immunol. 2021 Oct 13;12:738521. doi: 10.3389/fimmu.2021.738521. eCollection 2021. Front Immunol. 2021. PMID: 34721402 Free PMC article.

See all "Cited by" articles

References

1. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431. doi: 10.1056/NEJMoa054481. - DOI - PubMed
1. Bracha P, Moore NA, Ciulla TA, WuDunn D, Cantor LB. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol. 2018;63:281–295. doi: 10.1016/j.survophthal.2017.08.008. - DOI - PubMed
1. El Chehab H, Agard E, Russo A, Boujnah Y, Dot C. Intraocular Pressure Spikes after Aflibercept Intravitreal Injections. Ophthalmologica. 2016;236:43–47. doi: 10.1159/000446878. - DOI - PubMed
1. Jeong S, Sagong M, Chang W. Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report. BMC Ophthalmol. 2017;17:25. doi: 10.1186/s12886-017-0417-3. - DOI - PMC - PubMed
1. Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42:807–811. doi: 10.3129/i07-172. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program

[1] Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431. doi: 10.1056/NEJMoa054481. - DOI - PubMed

[2] Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431. doi: 10.1056/NEJMoa054481. - DOI - PubMed

[3] Bracha P, Moore NA, Ciulla TA, WuDunn D, Cantor LB. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol. 2018;63:281–295. doi: 10.1016/j.survophthal.2017.08.008. - DOI - PubMed

[4] Bracha P, Moore NA, Ciulla TA, WuDunn D, Cantor LB. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol. 2018;63:281–295. doi: 10.1016/j.survophthal.2017.08.008. - DOI - PubMed

[5] El Chehab H, Agard E, Russo A, Boujnah Y, Dot C. Intraocular Pressure Spikes after Aflibercept Intravitreal Injections. Ophthalmologica. 2016;236:43–47. doi: 10.1159/000446878. - DOI - PubMed

[6] El Chehab H, Agard E, Russo A, Boujnah Y, Dot C. Intraocular Pressure Spikes after Aflibercept Intravitreal Injections. Ophthalmologica. 2016;236:43–47. doi: 10.1159/000446878. - DOI - PubMed

[7] Jeong S, Sagong M, Chang W. Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report. BMC Ophthalmol. 2017;17:25. doi: 10.1186/s12886-017-0417-3. - DOI - PMC - PubMed

[8] Jeong S, Sagong M, Chang W. Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report. BMC Ophthalmol. 2017;17:25. doi: 10.1186/s12886-017-0417-3. - DOI - PMC - PubMed

[9] Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42:807–811. doi: 10.3129/i07-172. - DOI - PubMed

[10] Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42:807–811. doi: 10.3129/i07-172. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects

Collaborators

Affiliations

Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects

Authors

Collaborators

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials